100 related articles for article (PubMed ID: 27304192)
1. Systematic analyses and comprehensive field synopsis of genetic association studies in hepatocellular carcinoma.
Dong D; Zou Y; Zhang P; Wu Z
Oncotarget; 2016 Jul; 7(29):45757-45763. PubMed ID: 27304192
[TBL] [Abstract][Full Text] [Related]
2. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
3. Genetic polymorphisms of the multidrug resistance 1 gene MDR1 and the risk of hepatocellular carcinoma.
Wang ZC; Liu LZ; Liu XY; Hu JJ; Wu YN; Shi JY; Yang LX; Duan M; Wang XY; Zhou J; Fan J; Gao Q
Tumour Biol; 2015 Sep; 36(9):7007-15. PubMed ID: 25861753
[TBL] [Abstract][Full Text] [Related]
4. Lack of association of EPHX1 gene polymorphisms with risk of hepatocellular carcinoma: a meta-analysis.
Duan CY; Liu MY; Li SB; Ma KS; Bie P
Tumour Biol; 2014 Jan; 35(1):659-66. PubMed ID: 23955801
[TBL] [Abstract][Full Text] [Related]
5. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
6. Association between miR-499 rs3746444 and the susceptibility of hepatocellular carcinoma.
Yu H; Wang Y; Wang S; Sun N
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):42-5. PubMed ID: 27453271
[TBL] [Abstract][Full Text] [Related]
7. Interferon-γ +874A/T polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Zhou H; Wang L; Li X; Song J; Jiang T; Wu X; Zhou S
Med Sci Monit; 2015 Mar; 21():689-93. PubMed ID: 25739411
[TBL] [Abstract][Full Text] [Related]
8. Single nucleotide polymorphisms of MIR-149 gene rs2292832 contributes to the risk of hepatocellular carcinoma, but not overall cancer: a meta-analysis.
Jia H; Yu H; Liu Q
Minerva Med; 2016 Aug; 107(4):259-69. PubMed ID: 27348444
[TBL] [Abstract][Full Text] [Related]
9. Associations of genetic variants in the transcriptional coactivators EP300 and PCAF with hepatocellular carcinoma.
Akil A; Ezzikouri S; El Feydi AE; Benazzouz M; Afifi R; Diagne AG; Benjouad A; Dejean A; Pineau P; Benjelloun S
Cancer Epidemiol; 2012 Oct; 36(5):e300-5. PubMed ID: 22709982
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-12B+1188A/C polymorphism contributes to increased hepatocellular carcinoma susceptibility: evidence from a meta-analysis.
Peng Q; Li S; Lao X; Chen Z; Li R; Qin X
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):735-43. PubMed ID: 25445750
[TBL] [Abstract][Full Text] [Related]
11. Role of toll-like receptors gene polymorphism in hepatocellular carcinoma.
Lin W; Chen J; Zhu B; Xu X; Dong Z
J Recept Signal Transduct Res; 2014 Oct; 34(5):345-7. PubMed ID: 24641696
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
[TBL] [Abstract][Full Text] [Related]
13. The association of six non-synonymous variants in three DNA repair genes with hepatocellular carcinoma risk: a meta-analysis.
Shi YH; Wang B; Xu BP; Jiang DN; Zhao DM; Ji MR; Zhou L; Li X; Lu CZ
J Cell Mol Med; 2016 Nov; 20(11):2056-2063. PubMed ID: 27306318
[TBL] [Abstract][Full Text] [Related]
14. [Association between microRNA single nucleotide polymorphisms and the risk of hepatocellular carcinoma].
Li W; Ma Y; Zeng D; Zhang J; Wang R; Hu J; Yang D; Hu H; Wang J; Liu J
Rev Med Chil; 2016 Apr; 144(4):508-15. PubMed ID: 27401384
[TBL] [Abstract][Full Text] [Related]
15. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma.
Wu JS; Chen YP; Wang LC; Yang YJ; Deng CW; Hou BX; He ZL; Chen JX
Genet Mol Res; 2014 May; 13(2):3812-8. PubMed ID: 24938468
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity.
Wu X; Xin Z; Zhang W; Wu J; Chen K; Wang H; Zhu X; Pan L; Li Z; Li H; Liu Y
Int J Cancer; 2013 Sep; 133(5):1085-93. PubMed ID: 23404364
[TBL] [Abstract][Full Text] [Related]
17. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms in the promoter region of pri-miR-34b/c and risk of hepatocellular carcinoma.
Chen LL; Shen Y; Zhang JB; Wang S; Jiang T; Zheng MQ; Zheng ZJ; Chen CX
Genet Mol Res; 2016 Oct; 15(4):. PubMed ID: 27808368
[TBL] [Abstract][Full Text] [Related]
19. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
20. Genetic Polymorphisms of Cytochrome P4501A1 (CYP1A1) and Glutathione S-Transferase P1 (GSTP1) and Risk of Hepatocellular Carcinoma Among Chronic Hepatitis C Patients in Egypt.
Abo-Hashem EM; El-Emshaty WM; Farag Rel S; Zakaria S; Abd El-Aziz M; Ghonaim A
Biochem Genet; 2016 Oct; 54(5):696-713. PubMed ID: 27271262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
